Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Novo Nordisks Wegovy (semaglutide), the first and only once-weekly GLP-1 receptor agonist approved for weight management in people with obesity, has been found to help patients lose up to 15 percent of their body weight in over 68 weeks
Eligible clients get both the nutrition program and the medication through a single integrated experience
Unlike compounds that affect the vascular system, PT-141 acts on neurological pathways, making it of interest in behavioral neuroscience and melanocortin receptor studies
By targeting both the allergic response and the underlying inflammation in the nasal passages, Ryaltris provides comprehensive symptom control for people whose allergies are not fully managed with a single treatment
Base de evidencia: 2 estudios humanos y 30 preclinicos
US$ 26.29
US$ 22.83
US$ 24.24
US$ 23.06
US$ 21.59
US$ 20.08
US$ 27.11
US$ 20.37
US$ 28.91
